The Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease in about 20 years. Currently available Alzheimer’s drugs treat the disease’s symptoms. The newly-approved medicine, called Aduhelm, is the first to attack a substance that could be associated with the underlying causes of the disease — a toxic and sticky protein in the brain called amyloid.
The Alzheimer’s Association estimates that 6.0 million Americans 65 and older were living with the disease as of 2020, or 12% of the 65 and over population. As more and more of the baby boomer generation reaches that age, the number of Americans with the disease will inevitably increase.
The increase in the number of people 65 and over with Alzheimer’s disease in Louisiana between 2000 and 2025 is expected to be the 23rd largest at 19.6%. The number of older Americans with Alzheimer’s is projected to grow by 18.5% during that time.
As of last year, 92,000 Louisiana residents over the age of 65 have been diagnosed with the condition. The number is estimated to increase to 110,000 by 2025.
There were 2,165 deaths in Louisiana from Alzheimer’s disease in 2019, or 47 deaths per 100,000 residents, the 10th highest Alzheimer’s mortality rate in the country. While Louisiana’s share of the population 65 and older residents is among the smallest in the country, the share of people with Alzheimer’s in the age group is among the highest. About 13.2% of the state’s older residents are living with Alzheimer’s dementia, higher than the national average of 12.0%.
To determine the states where Alzheimer’s is soaring, 24/7 Wall St. reviewed the projected increase in the number of Americans 65 and older with Alzheimer’s disease between 2020 and 2025 in every state from the 2021 Alzheimer’s Association’s Alzheimer’s disease Facts and Figures report. These are the states where Alzheimer’s is expected to increase significantly.